[Increase in the antitumor effect of doxorubicin by complex corrections of the status of the hemostasis system].
Liubina
L V
LV
Baluda
V P
VP
Ziablitskiĭ
V M
VM
Mikhal'skaia
T Iu
TIu
Lepekhin
V P
VP
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D004176:Dipyridamole / Q000494:pharmacology; D004317:Doxorubicin / Q000494:pharmacology* / Q000627:therapeutic use; D005971:Glutamates / Q000494:pharmacology; D006487:Hemostasis / Q000502:physiology*; D006493:Heparin / Q000494:pharmacology; D008175:Lung Neoplasms / Q000097:blood / Q000188:drug therapy / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D009362:Neoplasm Metastasis
D005971:Glutamates; D004176:Dipyridamole; D004317:Doxorubicin; D006493:Heparin
Povyshenie protivoopukholevogo éffekta doksorubitsina kompleksnoĭ korrektsieĭ sostoianiia sistemy gemostaza.